Second-line treatments: moving towards an opportunity to improve survival in advanced gastric cancer?

Gastric cancer is the third leading cause of cancer-related death globally with approximately 723 000 deaths every year. Most patients present with advanced unresectable or metastatic disease, only amenable to palliative systemic treatment and a median survival uncommonly exceeding 12 months. Over t...

Full description

Saved in:
Bibliographic Details
Published in:ESMO Open
Main Authors: Salati, Massimiliano, Di Emidio, Katia, Tarantino, Vittoria, Cascinu, Stefano
Format: Artigo
Language:Inglês
Published: ESMO Open 2017
Subjects:
Review
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC5703389/
https://ncbi.nlm.nih.gov/pubmed/29209523
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/esmoopen-2017-000206
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items